Age- and sex-associated cardiac features and diagnostic latency in patients with ATTR-mixed and PN phenotypes assessed in a prospective multi-national real-world study

10 May 2026 (10:30 - 11:15)

Organised by:

Video

Sign in for access options

Abstract

Slides

About the speaker

Doctor Margot Davis

University of British Columbia, Vancouver (Canada)

4 More presentations in this session

Presentation thumbnail

Sex differences in heart failure outcomes: nationwide data from 2015 to 2023

Doctor D. Kosuta (Ljubljana, SI)

Abstract Slides Video

Presentation thumbnail

Sex differences in presentation, diagnostics, and outcomes across cardiomyopathies: insights from a prospective cohort.

Doctor C. Nordberg Backelin (Gothenburg, SE)

Abstract Slides Video

Presentation thumbnail

Community pharmacy as the main vaccinator in remotely monitored heart failure patients: sex- and age-related differences in vaccination pathways.

Professor N. Girerd (Nancy, FR)

Abstract Slides Video

Presentation thumbnail

Sex differences in adherence to guideline-directed medical therapy and their prognostic impact in HFrEF: insights from the KorAHF III registry

Doctor M. Kim (Seoul, KR)

Abstract Slides Video

Access the full session

Session thumbnail

Sex differences in heart failure

The Event

Event poster

Heart Failure 2026

10 May 2026 10:30 CET

You may be interested in

Congress Presentation

Wild-type transthyretin cardiac amyloidosis: sex differences in prevalence, phenotype, and prognosis

Congress Presentation

Tafamidis in women with wild-type transthyretin cardiac amyloidosis: an international cohort study

Congress Presentation

Sex-differences from referral to tafamidis treatment outcomes in real-world patients with wild-type transthyretin amyloid cardiomyopathy.

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources